R&D News | pharmaphorum

News

AZ launches digital clinical trials business

AstraZeneca has launched a separate business unit that will take what the drugmaker has learned from running digitally-powered clinical trials and offer that experience to

News

Bayer pulls atrial fibrillation study for asundexian

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded

News

ABPI says UK clinical trials sector ‘improving’

There are glimmers of a recovery in the UK’s clinical research sector, with an uptick in the number of new studies being started, according to a new report.

News

Study finds trials of prescription DTx often lack ‘rigour’

A retrospective analysis of the clinical data supporting 20 FDA-approved prescription digital therapeutics has found that they often fail to apply rigorous standards of ev

News

Australian retail pharmacy enters clinical trials market

Australian retail pharmacy chain Chemist Warehouse has made a move into the clinical trials market with the help of virtual research organisation ObvioHealth.

News

Gilde’s new investment fund reaches €740m at close

Netherlands-based investment group Gilde Healthcare has finally closed its new Venture & Growth VI fund with committed funding of €740 million, well ahead of its origi

AZ launches digital clinical trials business

Bayer pulls atrial fibrillation study for asundexian

ABPI says UK clinical trials sector ‘improving’

Study finds trials of prescription DTx often lack ‘rigour’

Australian retail pharmacy enters clinical trials market

Gilde’s new investment fund reaches €740m at close

It turns out COPD may be a laughing matter after all

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks